Breaking News

Velesco Pharma Expands

February 9, 2016

Opens new cGMP-compliant analytical testing laboratory

Velesco Pharma has boosted its cGMP analytical testing capabilities with an expansion of its analytical laboratory in Plymouth, MI. The addition of a new cGMP analytical testing laboratory increases the breadth of services to more fully meet the needs of its broad client base.

The main activity supported in the new cGMP-compliant laboratory is the testing of clients’ stability samples. Specific testing activity includes:

• Assay and related substances by HPLC (UV and RI) and UPLC-UV;
• Assay by titration; water content (Karl Fisher); pH; viscosity; osmolality; density/specific gravity; disintegration; dissolution and UV; and
• Hardness and friability for tablets

In addition to executing clients’ cGMP stability programs, the laboratory is ideal for the testing of samples for cleaning validation studies, in vitro equivalency determination and test article characterization.

“Our new cGMP analytical laboratory is impressively designed, equipped and staffed so that we can meet our clients’ growing demand for analytical services,” said Dave Barnes, chief executive officer, Velesco. “We look forward to collaborating with our clients to ensure strong cGMP testing programs. Our clients can be confident their testing will exceed FDA compliance requirements.”

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Why True CDMO Service Requires Flexibility, Responsiveness and Innovation

    James E. Gregory, UPM Pharmaceuticals||October 7, 2015
    Pharmaceutical and biopharmaceutical companies large and small are increasingly relying on third-party providers for support at all stages of drug development. To realize efficiencies, they are at the same time reducing the number of suppliers to a preferred few with whom they can form strategic partnerships.

  • CRO Outlook & Drug Development Trends

    CRO Outlook & Drug Development Trends

    Kristin Brooks , Contract Pharma||May 6, 2015
    CRO industry grows as increasingly complex R&D trends demand advanced expertise